Patient Access

What's Fueling the UK Private Healthcare Surge?
Business What's Fueling the UK Private Healthcare Surge?

A quiet but profound transformation is underway within the UK's health ecosystem, as what was once a supplementary service is rapidly becoming a mainstream necessity for a growing portion of the population. This shift is not just altering patient pathways but is also creating an unprecedented

AI Offers a Path to Equity in Women's Healthcare
Technology AI Offers a Path to Equity in Women's Healthcare

For generations, the architecture of modern medicine was constructed upon a foundation that largely excluded half the population, creating a profound knowledge debt that continues to compromise women's health outcomes today. This systemic oversight has resulted in a healthcare landscape where

South Korea Taps MedStar for Telehealth Expertise
Technology South Korea Taps MedStar for Telehealth Expertise

As nations around the globe race to modernize their healthcare infrastructures, South Korea’s National Health Insurance Service has turned to an American innovator for a blueprint on building a robust, patient-centric virtual care system. The recent visit by a South Korean delegation to MedStar H

Is AI for the Unhoused a Lifeline or an Experiment?
Technology Is AI for the Unhoused a Lifeline or an Experiment?

A pioneering but profoundly contentious initiative in California is deploying artificial intelligence to bridge the vast healthcare gap for the state's unhoused population, a move that places advanced technology at the intersection of medical ethics and social desperation. At the heart of this

China's Health Reform Improves Patient Flow and Access
Public Policy China's Health Reform Improves Patient Flow and Access

For a nation tasked with providing healthcare to over a billion people, redesigning the very architecture of its medical system represents a monumental feat of social engineering. Before its recent overhaul, China's healthcare landscape was a study in contrasts, characterized by world-class

Is the Era of the Biopharma Mega-Factory Over?
Care Is the Era of the Biopharma Mega-Factory Over?

The life-saving biologic drug in a hospital patient's IV drip likely began its journey years ago in a single, colossal factory thousands of miles away, a fact that represents both a triumph of modern science and a critical vulnerability. For decades, the biopharmaceutical industry has relied

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later